Open access
Jul 2026
Epigenetic reprogramming of terminal T cell differentiation via DNMT1 inhibition reverses terminal DNA methylation and enhances multipotency 2259880
An epigenetic approach is described that facilitates the reversal of repressive DNA methylation and is used to alter the fate of T cell subsets for immunotherapy and is now used to alter the fate of T cell subsets for immunotherapy.
A. Norman, Ben Youngblood, Caitlin C. Zebley
· Journal of Immunology · 0 citations